Tag: Pharmaceutical industry

First approved by the FDA in 2012 for stroke prevention, Eliquis became a blockbuster drug and a central part of a major pharmaceutical collaboration. The partnership responsible for who makes Eliquis medication involves two of the world's largest drug manufacturers, combining their resources to bring the anticoagulant to market.

As of October 2024, Eli Lilly is the most valuable drug company in the world with a market capitalization of $842 billion. This article explores the question: What is Eli Lilly known for, from its foundational role in medicine to its current market dominance?

According to a 2016 study published in *Health Affairs*, Medicare Part D patients paid average copayments more than 10 times higher for certain brand-name “me too” medications compared to their generic therapeutic alternatives. This stark statistic highlights the complex and often counterintuitive pricing of me too drugs within the pharmaceutical marketplace.

Although generic versions are available, a 2024 study noted that retail prices for the combination drug azelastine-fluticasone remained elevated due to markups from manufacturers and pharmacies. Multiple factors influence the final cost of azelastine, an effective antihistamine nasal spray, explaining why it can be surprisingly expensive for some consumers.

The average monthly list price for Wegovy (semaglutide) in the United States currently hovers around $1,349, making it a significant financial consideration for many patients seeking obesity treatment. This high cost raises a crucial question for patients and healthcare providers: **Will the price of Wegovy ever go down?** Understanding the dynamics of pharmaceutical pricing, patent protection, and market competition is essential to addressing this complex issue.

More than 25 brand-name and generic medications are currently approved for managing multiple sclerosis, with a diverse field of pharmaceutical companies dedicated to developing and manufacturing these vital treatments. This complex landscape is dominated by several major players who make MS drugs, alongside a growing number of smaller biotech firms.

At least 30% of antibiotics prescribed in outpatient settings are unnecessary, according to the Centers for Disease Control and Prevention. The question, 'Why are doctors so quick to prescribe drugs?' is complex, with reasons ranging from patient pressure to systemic issues in modern healthcare.

With more than 18 million people in the U.S. affected by major depressive disorder, Viibryd represents a crucial treatment option, but the pharmaceutical manufacturer behind this drug has a complex history. The brand-name version is currently produced by AbbVie Inc., though its origins trace back through a series of corporate acquisitions and licensing agreements.

In 2024, the global pharmaceutical market saw the top 50 best-selling drugs generate over $116 billion in revenue. Answering the question, 'What are the top 3 drugs used worldwide?', requires clarity, as the most widely used medicines by volume (often cheap generics) differ significantly from the most profitable ones by sales revenue. Based on 2024 revenue, the pharmaceutical market's top three blockbuster drugs are Merck's Keytruda, Novo Nordisk's Ozempic, and Bristol Myers Squibb/Pfizer's Eliquis.

According to Drugs.com, all strengths of the cholesterol medication Altoprev have been discontinued, and its manufacturer was Covis Pharma. Discover the history of this drug and who is the manufacturer of Altoprev, the extended-release lovastatin tablet, as well as its availability and alternatives.